comparemela.com

Page 3 - Suresh Katta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Carlyle group leads $430 million buyout of Saama Technologies - Silicon Valley Business Journal

Carlyle group leads $430 million buyout of Saama Technologies - Silicon Valley Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Saama Raises Up To $430M Investment

Drug development advancements call for skilled workforce

Drug development advancements call for skilled workforce According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes. Suresh Katta, CEO and founder of Saama Technologies, spoke with Outsourcing-Pharma about the rapid technological advancements in the drug development field, and how companies can cultivate a workforce capable of keeping up. OSP: Could you please talk about some of the shifts in and demands on the clinical trial industry that are changing what we expect of study and drug-development personnel?​ SK: We are beginning an exciting new era when drug development teams can look at artificial intelligence (AI) as a welcomed new co-worker. AI is enabling them to take clinical study strategy and design to a superior level.

Saama Appoints Ian Holmes, Ph D , to Swiss Board of Directors

Saama Appoints Ian Holmes, Ph.D., to Swiss Board of Directors Posted Jan 14, 2021 Saama Appoints Ian Holmes, Ph.D., to Swiss Board of Directors   Wide spectrum of pharma and CRO experience Extensive global clinical trial operations and management expertise   CAMPBELL, CA – (January 14, 2021) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that Ian Holmes, Ph.D., has joined its Swiss Board of Directors, effective January 1, 2021. Based in Zurich, Dr. Holmes brings over 40 years of drug research and development experience and expertise to Saama’s European presence.   Most recently Dr. Holmes held the position of Senior Vice President of Corporate Development at the CRO PharmaNet, now Syneos Health Clinical. As a member of the PharmaNet Global Executive Committee, he was charged with effecting the geographical expansion and globalization of the company, with emphasis on Europe, Asia, Australasia, an

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.